Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9615 posts found.

ianread

Pharma CEO Ian Read forcasts rebate-free drug market

August 1, 2018 Research and Development CEO, Ian Read, PBMs, Pfizer, Rebates

The CEO of American multinational Pfizer has said that he believes the Trump administration will eliminate rebates on prescription drug …
News
john-milligan-thumbnail-300x300

Gilead’s CEO and Chairman to both step down before year’s end

July 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …
Appointment

Living with Behçet’s disease

July 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Behçet's disease, patient experience, pharma

Suzanne Morris speaks to Pharmafocus to discuss her life with Behçet’s disease, a rare condition characterised by the inflammation of …
Feature
shutterstock_38078521

Tonix plunges 68% after PTSD drug failure

July 30, 2018 Research and Development, Sales and Marketing PTSD, Tonmya, pharma, tonix

Tonix Pharmaceuticals has announced that it has terminated its Phase 3 study of Tonmya (cyclobenzaprine HCl sublingual tablets) in military-related …
News
sean-harper

Amgen announces resignation of two top executives

July 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Anthony C Cooper, R&D, biotech, retire, sean harper

Amgen’s head of R&D, Dr Sean Harper, has announced that he is retiring from his current position as Executive Vice …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, China, GSK, Gilead, J&J, JJ, Pfizer, Remicade, Roche, antimicrobial resistance, biosimilar, pharma, pricing, viagra

With the UK in the grip of a record-breaking heatwave, it’s hard to focus on much else over here, but …
News
takeda_usa_pharmaceuticals_u

Takeda’s Alunbrig topples Pfizer’s Xalkori in ALK-positive lung cancer

July 27, 2018 Medical Communications, Research and Development Alunbrig, Cancer, NSCLC, Pfizer, Takeda, Xalkori, lung cancer, pharma

Takeda has unveiled new Phase 3 data showing that its tyrosine kinase inhibitor (TKI) Alunbrig (brigatinib) not only met its …
News
gsk_boronia_australia

GSK forges $300m partnership with 23andMe to boost preclinical R&D

July 26, 2018 Research and Development 23andME, GSK, GlaxoSmithKline, collaboration, genetics, pharma

In a bid to supercharge its drug discovery efforts, GlaxoSmithKline has sealed a $300 million deal with personal genomics and …
News

Merck KGaA announces new Senior Vice President, Head of Global Affairs

July 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Maria Rivas, Germany, Merck, Merck KGaA, research and development

Merck KGaA has announced the appointment of Dr Maria Rivas as Senior Vice President, Head of Global Affairs. Dr Rivas, …
Appointment

Gilead’s CEO and Chairman to both step down before year’s end

July 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …
News
394px-ad_versus_co

Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials

July 26, 2018 Research and Development Alzheimer's disease, BAN2401, Biodgen, Eisai, phase 2, research

An experimental drug developed by the Massachusetts-based multinational Biogen and their Japanese partner Eisai has been shown to significantly slow …
News
Matt Hancock

NHS to stockpile drugs in preparation for no-deal Brexit

July 25, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, brexit, government, pharma, stockpiling

Secretary of State for Health and Social Care, Matt Hancock, has said that the NHS is preparing to stockpile medicines …
News

FDA approves first endometriosis pain management drug in a decade

July 25, 2018 Research and Development, Sales and Marketing AbbVie, FDA, Neurocrine Biosciences, endometriosis, pharma

The FDA has confirmed its approval of AbbVie and Neurocrine Biosciences’ Orilissa (elagolix), a nonpeptide small molecule gonadotropin-releasing hormone (GnRH) …
News

HPV vaccine to be given to boys in England

July 25, 2018 Research and Development Cancer, HPV, infectious disease, sexually transmitted diseases, vaccines, virus

The government has announced that boys in England aged 12 and 13 will be vaccinated against Human Papilloma Virus (HPV) …
News

Pfizer to build $465m sterile injectable plant in Michigan

July 25, 2018 Manufacturing and Production, Research and Development Michigan, Pfizer, US, manufacturing, pharma

Pfizer has unveiled plans to invest $465 million to build a new sterile injectables plant in Portage, Michigan, saying that …
News
The Gateway to Local Adoption Series

Latest content

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026